Hypolipidaemic Effects of (24R)-4α-methyl-5α-stigmasta-7,22-dien-3β-ol Derived from Aurantiochytrium mangrovei BT3 in the HEPG2 Cell Line

[1]  Grace Guo,et al.  Intake of stigmasterol and β-sitosterol alters lipid metabolism and alleviates NAFLD in mice fed a high-fat western-style diet. , 2018, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[2]  C. Correll,et al.  The pharmacological management of metabolic syndrome , 2018, Expert review of clinical pharmacology.

[3]  P. Nichols,et al.  Taxonomy, ecology and biotechnological applications of thraustochytrids: A review. , 2017, Biotechnology advances.

[4]  D. D. Hong,et al.  Squalene promotes cholesterol homeostasis in macrophage and hepatocyte cells via activation of liver X receptor (LXR) α and β , 2017, Biotechnology Letters.

[5]  Philippe Lefebvre,et al.  Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. , 2015, Journal of hepatology.

[6]  H. L. Anh,et al.  Extraction of squalene as value-added product from the residual biomass of Schizochytrium mangrovei PQ6 during biodiesel producing process. , 2014, Journal of bioscience and bioengineering.

[7]  R. Jiao,et al.  Algal sterols are as effective as β-sitosterol in reducing plasma cholesterol concentration. , 2014, Journal of agricultural and food chemistry.

[8]  D. Francis,et al.  Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations , 2013, International journal of cardiology.

[9]  T. Kawada,et al.  Aloe vera phytosterols act as ligands for PPAR and improve the expression levels of PPAR target genes in the livers of mice with diet-induced obesity. , 2011, Obesity research & clinical practice.

[10]  R. Armenta,et al.  Use of raw glycerol to produce oil rich in polyunsaturated fatty acids by a thraustochytrid. , 2011, Enzyme and microbial technology.

[11]  F. Blanco-Vaca,et al.  New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism. , 2009, Atherosclerosis.

[12]  Jennifer G. Robinson,et al.  Lipid-lowering effects of statins: a comparative review , 2006, Expert opinion on pharmacotherapy.

[13]  T. Yanagita,et al.  Campest-5-en-3-one, an oxidized derivative of campesterol, activates PPARalpha, promotes energy consumption and reduces visceral fat deposition in rats. , 2006, Biochimica et biophysica acta.

[14]  C. Barrow,et al.  Isolation and characterization of polyunsaturated fatty acid producing Thraustochytrium species: screening of strains and optimization of omega-3 production , 2006, Applied Microbiology and Biotechnology.

[15]  S. Pal,et al.  Margarine phytosterols decrease the secretion of atherogenic lipoproteins from HepG2 liver and Caco2 intestinal cells. , 2005, Atherosclerosis.

[16]  S. Grundy,et al.  History and development of plant sterol and stanol esters for cholesterol-lowering purposes. , 2005, The American journal of cardiology.

[17]  Sander Kersten,et al.  Roles of PPARs in health and disease , 2000, Nature.

[18]  W. Wahli,et al.  Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. , 1997, Molecular endocrinology.

[19]  T. Yokota,et al.  Triterpene Alcohols and Sterols from the Fern Gleichenia japonica SPR. , 1993 .